Top

Published in:

01-02-2012 | Original Article

T-helper-related cytokines in gingival crevicular fluid from adolescents with Down syndrome

Authors: Georgios Tsilingaridis, Tülay Yucel-Lindberg, Thomas Modéer

Published in: Clinical Oral Investigations | Issue 1/2012

Abstract

Subjects with Down syndrome have a high prevalence of periodontal disease. The aim was to investigate the level of Th1-, Th2- and Th17-related cytokines in the gingival crevicular fluid (GCF) of subjects with Down syndrome. Subjects with Down syndrome (n = 24) and controls (n = 29) with a mean age of 16.4 years were clinically examined with respect to periodontal probing depth (PD) and gingival inflammation in terms of bleeding on probing (BOP%). The controls were matched to subjects with Down syndrome regarding age and gingival inflammation (BOP%). All subjects answered a questionnaire regarding oral hygiene, medical history and socioeconomic background. GCF was collected and the concentration of the cytokines, IFN-γ, TNF-α, IL-1β, IL-4, IL-6, IL-10, IL-12 and IL-17 were determined using Bio-Plex cytokine multiplex assays. The volume of GCF (microliters) was significantly higher in subjects with Down syndrome (P < 0.001) compared with controls. The mean concentrations (picogrammes per millilitre) of IL-1β (P < 0.001), IL-4 (P = 0.002), IL-6 (P = 0.005), IL-10 (P = 0.001), IL-12 (P = 0.003), IFN-γ (P = 0.002), and TNF-α (P = 0.002) in GCF, respectively, were significantly higher in subjects with Down syndrome compared with controls. The regression line of the relationship between IFN-γ and IL-4 in GCF differed significantly (P = 0.006) in subjects with Down syndrome compared to controls. Subjects with Down syndrome demonstrated higher concentration of Th1-, Th2- and Th17-related cytokines with an altered relationship between Th1 cytokine, IFN-γ and Th2 cytokine, IL-4, in volume GCF compared to controls.

Lejeune J, Gautier M, Turpin R (1959) Study of somatic chromosomes from nine mongoloid children. C R Hebd Seances Acad Sci 248:1721–1722PubMed

Pueschel SM, Annerén G, Durlach R, Flores J, Sustrová M, Verma IC (1995) Guidelines for optimal medical care of persons with Down syndrome. International league of societies for persons with mental handicap. Acta Paediatr 84:823–827PubMedCrossRef

Modéer T, Barr M, Dahllöf G (1990) Periodontal disease in children with Down's syndrome. Scand J Dent Res 98:228–234PubMed

Reuland-Bosma W, van Dijk J (1986) Periodontal disease in Down's syndrome: a review. VJ Clin Periodontol 13:64–73CrossRef

Levin S (1987) The immune system and susceptibility to infections in Down's syndrome. Prog Clin Biol Res 246:143–162PubMed

Barkin RM, Weston WL, Humbert JR, Maire F (1980) Phagocytic function in Down syndrome—I. Chemotaxis. J Ment Defic Res 24:243–249PubMed

Barkin RM, Weston WL, Humbert JR, Sunada K (1980) Phagocytic function in Down syndrome—II. Bactericidal activity and phagocytosis. J Ment Defic Res 24:251–256PubMed

Murphy M, Lempert MJ, Epstein LB (1990) Decreased level of T-cell receptor expression by Down syndrome (trisomy 21) thymocytes. Am J Med Genet Suppl 7:234–237PubMed

Murphy M, Friend DS, Pike-Nobile L, Epstein LB (1992) Tumour necrosis factor-alpha and IFN-gamma expression in human thymus. Localisation and overexpression in Down syndrome (trisomy 21). J Immunol 149:2506–2512PubMed

10.

de Hingh YC, van der Vossen PW, Gemen EF et al (2005) Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr 147:744–747PubMedCrossRef

11.

Zhu J, Paul WE (2008) CD4 T-cells: fates, functions and faults. Blood 112:1557–1569PubMedCrossRef

12.

Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485–517PubMedCrossRef

13.

Mosmann TR, Kobie JJ, Lee FE, Quataert SA (2009) T-helper cytokine patterns: defined subsets, random expression and external modulation. Immunol Res Feb 6. (In press)

14.

Kusters MA, Verstegen RH, Gemen EF, de Vries E (2009) Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol 156:189–193PubMedCrossRef

15.

Tsilingaridis G, Yucel-Lindberg T, Modéer T (2003) Enhanced levels of prostaglandin E2, leukotriene B4 and matrix metalloproteinase-9 in gingival crevicular fluid from patients with Down syndrome. Acta Odontol Scand 61:154–158PubMedCrossRef

16.

Barr-Agholme M, Krekmanova L, Yucel-Lindberg T, Shinoda K, Modéer T (1997) Prostaglandin E2 level in gingival crevicular fluid from patients with Down syndrome. Acta Odontol Scand 55:101–105PubMedCrossRef

17.

Offenbacher S, Odle BM, Van Dyke TE (1986) The use of crevicular fluid prostaglandin E₂ levels as a predictor of periodontal attachment loss. J Periodontal Res 21:101–112PubMedCrossRef

18.

Offenbacher S, Odle BM, Braswell LD et al (1989) Change in cyclooxygenase metabolites in experimental periodontitis in Macaca mulatta. J Periodontal Res 24:63–74PubMedCrossRef

19.

Offenbacher S, Heasman PA, Collins JG (1993) Modulation of host PGE₂ secretion as a determinant of periodontal disease expression. J Periodontol 64:432–444PubMed

20.

Goodwin JS, Ceuppens J (1983) Regulation of the immune response by prostaglandins. J Clin Immunol 3:295–315PubMedCrossRef

21.

Gold KN, Weyand CM, Goronzy JJ (1994) Modulation of helper T-cell function by prostaglandins. Arthritis Rheum 37:925–933PubMedCrossRef

22.

Hilkens CM, Vermeulen H, van Neerven RJ, Snijdewint FG, Wierenga EA, Kapsenberg ML (1995) Differential modulation of T-helper type 1 (Th1) and T-helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur J Immunol 25:59–63PubMedCrossRef

23.

Yao C, Sakata D, Esaki Y et al (2009) Prostaglandin E₂-EP4 signalling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med 6:633–641CrossRef

24.

Wood CES, Jones AA RC, Newbold DA, Manwell MA, Kornman KS (1993) Relationship of “bleeding on probing” and “gingival index bleeding” as clinical parameters of gingival inflammation. J Clin Periodontol 20:139–143PubMedCrossRef

25.

Källestål C, Matsson L (1989) Criteria for assessment of interproximal bone loss on bitewing radiographs in adolescents. J Clin Periodontol 16:300–304PubMedCrossRef

26.

Morgan J (2007) Why is periodontal disease more prevalent and more severe in people with Down syndrome? Spec Care Dent 27:196–201CrossRef

27.

Faulks D, Collado V, Mazille MN, Veyrune JL, Hennequin M (2008) Masticatory dysfunction in persons with Down's syndrome. Part 1: aetiology and incidence. J Oral Rehabil 35:854–862PubMedCrossRef

28.

Bloemers BL, van Bleek GM, Kimpen JL, Bont L (2010) Distinct abnormalities in the innate immune system of children with Down syndrome. J Pediatr 156:804–809PubMedCrossRef

29.

Ziegler-Heitbrock HW, Fingerle G, Strobel M et al (1993) The novel subset of CD14⁺/CD16⁺ blood monocytes exhibits features of tissue macrophages. Eur J Immunol 23:2053–2058PubMedCrossRef

30.

Frankenberger M, Sternsdorf T, Pechumer H, Pforte A, Ziegler-Heitbrock HW (1996) Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 87:373–377PubMed

31.

Mobley JL, Leininger M, Madore S, Baginski TJ, Renkiewicz R (2007) Genetic evidence of a functional monocyte dichotomy. Inflammation 30:189–197PubMedCrossRef

32.

Szabo G, Miller-Graziano CL, Wu JY, Takayama T, Kodys K (1990) Differential tumor necrosis factor production by human monocyte subsets. J Leukoc Biol 47:206–216PubMed

33.

Ziegler-Heitbrock L (2007) The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 81:584–592, ReviewPubMedCrossRef

34.

Guazzarotti L, Trabattoni D, Castelletti E et al (2009) T lymphocyte maturation is impaired in healthy young individuals carrying trisomy 21 (Down syndrome). Am J Intellect Dev Disabil 114:100–109PubMedCrossRef

35.

Cetiner S, Demirhan O, Inal TC, Tastemir D, Sertdemir Y (2010) Analysis of peripheral blood T-cell substets, natural killer cells and serum levels of cytokines in children with Down syndrome. Int J Immunogenet 37(4):233–237PubMedCrossRef

36.

Harris SG, Padilla J, Koumas L, Ray D, Phipps RP (2002) Prostaglandins as modulators of immunity. Trends Immunol 23:144–150PubMedCrossRef

37.

Halinen S, Sorsa T, Ding Y et al (1996) Characterisation of matrix metalloproteinase (MMP-8 and -9) activities in the saliva and in gingival crevicular fluid of children with Down's syndrome. Periodontol 67:748–754

38.

Sarén P, Welgus HG, Kovanen PT (1996) TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1;157(9):4159–4165

39.

Zhou M, Zhang Y, Ardans JA, Wahl LM (2003) Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8. J Biol Chem 14;278(46):45406–45413CrossRef

Title: T-helper-related cytokines in gingival crevicular fluid from adolescents with Down syndrome
Authors: Georgios Tsilingaridis
Tülay Yucel-Lindberg
Thomas Modéer
Publication date: 01-02-2012
Publisher: Springer-Verlag
Published in: Clinical Oral Investigations / Issue 1/2012
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-010-0495-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

T-helper-related cytokines in gingival crevicular fluid from adolescents with Down syndrome

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2012

Curing efficiency of modern LED units

Micromechanical properties of veneer luting resins after curing through ceramics

Retention of orthodontic brackets bonded with resin-modified GIC versus composite resin adhesives—a quantitative systematic review of clinical trials

Wound healing following regenerative procedures in furcation degree III defects: histomorphometric outcomes

Oxidative stress and cytotoxicity generated by dental composites in human pulp cells

Hydrogen peroxide release kinetics into saliva from different whitening products: a double-blind, randomized clinical trial